Blood viscosity at different stages of diabetes pathogenesis

British Journal of Biomedical Science

Volumn 67, Issue 2, 2010, Pages 67-70

  Richards, R S ^a   Nwose, Ezekiel U ^a,b  

^a CHARLES STURT UNIVERSITY   (Australia)

^b Institute of Clinical Pathology and Medical Research   (Australia)

Author keywords

Blood viscosity; Cardiovascular diseases; Diabetes mellitus; Oxidative stress

Indexed keywords

GLUTATHIONE; MALONALDEHYDE; METHEMOGLOBIN;

ADULT; AGED; ARTICLE; BLOOD VISCOSITY; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 77954265964     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: 10.1080/09674845.2010.11730293     Document Type: Article

References (22)

1. Higgins C. Recurrence of venous thromboembolism. The Biomedical Scientist 2006; 50 (10): 865-7.
2. Tamariz LJ, Young JH, Pankow JS et al. Blood viscosity and hematocrit as risk factors for type 2 diabetes mellitus: the atherosclerosis risk in communities (ARIC) study. Am J Epidemiol 2008; 168 (10): 1153-60.
3. Lowe GD, Lee AJ, Rumley A, Price JF, Fowkes FG. Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study. Br J Haematol 1997; 96 (1): 168-73.
4. Beder I, Kittova M, Mataseje A, Carsky J, Orszaghova Z, Babinska K. Effects of selected substances with antiglycative and antioxidative properties on erythrocyte deformability in diabetes patients. Scripta Medica 2002; 75 (5): 239-44.
5. Jayavanth S, Singh M. Changes in erythrocyte aggregation and deformability during human ageing. Curr Sci 2002; 82 (2): 191-6.
6. Boivin P. Molecular interactions of membrane proteins and erythrocyte deformability. Pathol Biol (Paris) 1984; 32 (6): 717-35.
7. Suda T, Maeda N, Shiga T. Effect of cholesterol on human erythrocyte membrane: a spin label study. J Biochem (Tokyo) 1980; 87 (6): 1703-13.
8. Solans R, Motta C, Solá R et al. Abnormalities of erythrocyte membrane fluidity, lipid composition and lipid peroxidation in systemic sclerosis: evidence of free radical-mediated injury. Arthritis Rheum 2000; 43 (4): 894-900.
9. Yang ZC, Xia K, Wang L et al. Asymmetric dimethylarginine reduced erythrocyte deformability in streptozotocin-induced diabetic rat. Microvasc Res 2007; 73 (2): 131-6.
10. Lowe GD. Measurement of thrombosis and its prevention. Br J Clin Pharmacol 2002; 54 (1): 96-100.
11. Nwose EU, Richards RS, Kerr PG, Tinley P, Jelinek HF. Oxidative damage indices for the assessment of subclinical diabetic macrovascular complications. Br J Biomed Sci 2008; 65 (3): 136-41.
12. Richards RS, Roberts TK, McGregor NR, Dunstan RH, Butt HL. Blood parameters indicative of oxidative stress are associated with symptom expression in chronic fatigue syndrome. Redox Rep 2000; 5 (1): 35-41.
13. Richards RS, Roberts TK, Dunstan RH, McGregor NR, Butt HL. Erythrocyte antioxidant systems protect cultured endothelial cells against oxidant damage. Biochem Mol Biol Int 1998; 46 (5): 857-65.
14. Richards RS, Roberts TK, Mathers D, Dunstan RH, McGregor NR, Butt HL. Erythrocyte morphology in rheumatoid arthritis and chronic fatigue syndrome: a preliminary study. J Chronic Fatigue Syndr 2000; 6: 23-35. (Pubitemid 30417752)
15. Nwose EU, Richards RS, Jelinek HF, Kerr PG. D-dimer identifies stages in the progression of diabetes mellitus from family history of diabetes to cardiovascular complications. Pathology 2007; 39 (2): 252-7.
16. Cosyns B, Droogmans S, Hernot S et al. Effect of streptozotocin-induced diabetes on myocardial blood flow reserve assessed by myocardial contrast echocardiography in rats. Cardiovasc Diabetol 2008; 7: 26 (www.pubmedcentral. nih.gov/picrender.fcgi?artid=2546381&blobtype=pdf)
17. Nwose EU, Jelinek HF, Richards RS, Kerr PG. Erythrocyte oxidative stress in clinical management of diabetes and its cardiovascular complications. Br J Biomed Sci 2007; 64 (1): 35-43. (Pubitemid 46952971)
18. Vigilance JE, Reid HL. Glycaemic control influences peripheral blood flow and haemorheological variables in patients with diabetes mellitus. Clin Hemorheol Microcirc 2005; 33 (4): 337-46.
19. Da Ros R, Assaloni R, Ceriello A. Antioxidant therapy in diabetic complications: what is new? Curr Vasc Pharmacol 2004; 2 (4): 335-41.
20. Nwose EU, Jelinek HF, Richards RS, Kerr PG. Cardiovascular drugs do not significantly alleviate oxidative stress (Conference Proceedings). Heart Foundation Conference and Scientific Meeting, Sydney, 2006.
21. Zhang ZX, Zhu LZ, Zhong JB. Clinical observation on effect of tiaozhi jiangtang tablet on patients with diabetes of blood stasis syndrome: a report of 30 cases (in Chinese). Zhongguo Zhong Xi Yi Jie He Za Zhi 2006; 26 (1): 72-4.
22. Walsh M, Spurling G. Aspirin in type 2 diabetes: is there any evidence base? BMJ 2008; 337: a1902. doi: 10.1136/bmj.a1902. (www.bmj.com/cgi/content/ full/337/oct16-1/a1902?maxtoshow=&HITS=10&hits=10&RESULTFORMAT= &fulltext=prediabetes&searchid=1&FIRSTINDEX=0&resourcetype= HWCIT).